National Guideline Clearinghouse | Guidelines by Topic: Stomach Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Stomach Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2257) > Neoplasms (588) > Neoplasms by Site (435) > Digestive System Neoplasms (101) >Gastrointestinal Neoplasms (70) >

Stomach Neoplasms (9)

1-9 of 9
1.   Fluorouracil chemotherapy: the My5-FU assay for guiding dose adjustment. 2014 Dec 10. NGC:010621 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
2.   Imatinib for the adjuvant treatment of gastrointestinal stromal tumours (review of NICE technology appraisal guidance 196). 2010 Aug (revised 2014 Nov). NGC:010615 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
3.   ACR Appropriateness Criteria® resectable stomach cancer. 2014. NGC:010683 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
4.   Neoadjuvant or adjuvant therapy for resectable gastric cancer. 2000 Dec 6 (revised 2011 Apr 5). NGC:009857 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
5.   Systemic therapy for advanced gastric cancer. 2010 Dec 16. NGC:008091 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
6.   Capecitabine for the treatment of advanced gastric cancer. 2010 Jul. NGC:008063 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
7.   Laboratory medicine practice guidelines: use of tumor markers in liver, bladder, cervical, and gastric cancers. 2010. NGC:007967 National Academy of Clinical Biochemistry - Professional Association. View all guidelines by the developer(s) Compare Selected
8.   Recommendations in primary care for the most efficacious and cost effective pharmacologic treatment forHelicobacter pylori in non-pregnant adults. 2013 May. NGC:009914 University of Texas at Austin School of Nursing, Family Nurse Practitioner Program - Academic Institution. View all guidelines by the developer(s) Compare Selected
9.   The role of IMRT in gastrointestinal cancers. 2010 Oct 29. NGC:008826 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)